Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
Open Access
- 27 July 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 9 (1), 1-10
- https://doi.org/10.1186/1476-4598-9-198
Abstract
Background Non-small-cell lung cancer (NSCLC) is the leading cause of cancer death. Early detection of NSCLC will improve its outcome. The current techniques for NSCLC early detection are either invasive or have low accuracy. Molecular analyses of clinical specimens present promising diagnostic approaches. Non-coding RNAs (ncRNAs) play an important role in tumorigenesis and could be developed as biomarkers for cancer. Here we aimed to develop small nucleolar RNAs (snoRNAs), a common class of ncRNAs, as biomarkers for NSCLC early detection. The study comprised three phases: (1) profiling snoRNA signatures in 22 NSCLC tissues and matched noncancerous lung tissues by GeneChip Array, (2) validating expressions of the signatures by RT-qPCR in the tissues, and (3) evaluating plasma expressions of the snoRNAs in 37 NSCLC patients, 26 patients with chronic obstructive pulmonary disease (COPD), and 22 healthy subjects. Results In the surgical tissues, six snoRNAs were identified, which were overexpressed in all tumour tissues compared with their normal counterparts. The overexpressions of the genes in tumors were confirmed by RT-qPCR. The snoRNAs were stably present and reliably detectable in plasma. Of the six genes, three (SNORD33, SNORD66 and SNORD76) displayed higher plasma expressions in NSCLC patients compared with the cancer-free individuals (All < 0.01). The use of the three genes produced 81.1% sensitivity and 95.8% specificity in distinguishing NSCLC patients from both normal and COPD subjects. The plasma snoRNA expressions were not associated with stages and histological types of NSCLC (All > 0.05). Conclusions The identified snoRNAs provide potential markers for NSCLC early detection.Keywords
This publication has 44 references indexed in Scilit:
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Non-coding RNAs: a key to future personalized molecular therapy?Genome Medicine, 2010
- Implication of snoRNA U50 in human breast cancerJournal of Genetics and Genomics, 2009
- GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancerOncogene, 2008
- Unique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell, 2006
- Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia—a reviewClinical and Translational Oncology, 2005
- Small regulatory RNAs in mammalsHuman Molecular Genetics, 2005
- Noninvasive Staging of Non-small Cell Lung Cancer*Chest, 2003
- Small Nucleolar RNAsCell, 2002
- Emerging views on tmRNA‐mediated protein tagging and ribosome rescueMolecular Microbiology, 2001